Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?

Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Pul, Refik, Osmanovic, Alma, Schmalstieg, Holger, Pielen, Amelie, Pars, Kaweh, Schwenkenbecher, Philipp, Sühs, Kurt Wolfram, Yildiz, Özlem, Frank, Benedikt, Stangel, Martin, Skripuletz, Thomas
Format: Artigo
Langue:Inglês
Publié: MDPI 2016
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5187906/
https://ncbi.nlm.nih.gov/pubmed/27983657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17122106
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires